Felice Tsui

Felice Tsui has a diverse work experience in various organizations, starting from 2015. Felice worked as an Associate Director of Patient Advocacy & Medical Affairs at Editas Medicine from March 2023 to the present. Before that, they worked as a Patient Advocacy Consultant at KorInsight, Inc. starting from March 2023. From 2022 to 2022, they served as an Associate Director of Patient Advocacy & Affairs at X4 Pharmaceuticals. Prior to that, they worked at Columbia University Mailman School of Public Health as a Scientific Program Manager in Epidemiology from October 2020 to March 2022. Felice also worked as a Research Assistant at New York State Psychiatric Institute and NYU Langone Health in 2020. Earlier in their career, they held positions at Roivant Sciences, Real Chemistry, and The Hoffman Agency in various roles such as Manager, Intern, and Public Relations Intern.

Felice Tsui completed a Bachelor's Degree in Communications from UC Santa Barbara in the years 2010 to 2014. They then pursued a Master of Public Health degree with a focus on Epidemiology from Columbia University Mailman School of Public Health from 2019 to 2021. Additionally, they obtained a certification in "Measurement, Design, and Analysis Methods for Health Outcomes Research" from Harvard T.H. Chan School of Public Health in the year 2022. Felice also spent a year studying Communication and Media Studies at the National University of Singapore in 2012-2013, but it is not mentioned whether a degree was obtained from this institution.